Postdoctoral Training Fellow in Cancer MRI

05/04/2021, 23:55

Sutton (Greater London)
Radiotherapy and Imaging
Quant Biomed Imaging
Full time
Fixed Term
3 years
35
£32,844 - £40,902
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

The ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top five cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The Quantitative Biomedical Imaging (QBI) Team uses MRI, CT and other imaging modalities to develop and validate imaging biomarkers of tumour structure and function. Our work spans preclinical, first-in-human and translational imaging across a range of biological models, tumour types and therapies.
The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment.

The post holder will develop data acquisition strategies for oxygen-enhanced MRI. The subsequent aim is to then these methods to a clinical study evaluating how tumour hypoxia affects the effectiveness of novel targeted therapies.

The appointee will work as part of a multi-disciplinary team of image analysis scientists, imaging physicists, mathematicians, statisticians and clinicians. We are seeking a highly motivated individual with a strong publication track record and excellent team working skills who will drive the research program forward. Work arrangements are flexible with a proportion of time allowed for working at home as negotiated with the line manager.
Candidates should hold a PhD in a relevant field (computer science, mathematics, physics or closely-related topic). Having state registration as a Medical Physicist would be desirable, but is not essential. They should have experience in both advanced medical image analysis (particularly CT and MRI) and in mathematical modelling, data mining and machine learning. Strong scientific programming skills in programmes such as C, C++, Matlab and Python are essential. Experience in working in clinical imaging research studies is expected (preferably cancer).

The salary range is £32,844* - £40,902. This a fixed-term appointment for 3 years in the first instance. The starting salary will be based on previous postdoctoral experience and future progression is based on annual performance review.
*If the candidate has not yet been awarded their PhD, the salary will be set at £32,844 until the successful completion of their viva.

To apply please submit an application online on the ICR Careers site, attaching your CV with the supporting statement (addressing with specific examples where you meet the person specification, a brief description of your relevant experience and incl. the names and addresses of at least two referees).

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

The ICR is the leading academic research centre in the UK. Effective industry collaboration and innovation in new medicines and technologies are at the heart of our approach to drive benefits for patients. The ICR is ranked:

 

  • first for the quality and impact of our research*
  • second worldwide for the number of our publications cited in patents**
  • fourth worldwide for the citation rate of scientific research published across all fields**
  • fourth worldwide for top-cited research publications**
  • in the top five higher education institutions worldwide for academic influence and commercial impact**

 

*2014 Research Excellence Framework

** U-Multirank, 2020

Additional Documentation for Candidates

This Program is closed to applications.